Who can get access to GLP1 agonists?
A special family of medications known as glucagon-like peptide-1 receptor agonists (GLP-1) has been licensed for the treatment of both diabetes and obesity. In this video, Mr. Ahmed Ahmed is telling us who can have access to glp1 agonists.